| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1997PNAS...94.4610B |
| P356 | DOI | 10.1073/PNAS.94.9.4610 |
| P932 | PMC publication ID | 20771 |
| P698 | PubMed publication ID | 9114038 |
| P5875 | ResearchGate publication ID | 24451693 |
| P2093 | author name string | J Petersen | |
| A Mayer | |||
| C Thivolet | |||
| C Rask | |||
| C Czerkinsky | |||
| J Holmgren | |||
| V Moulin | |||
| N Fabien | |||
| C Ploix | |||
| I Bergerot | |||
| M Lindblad | |||
| P2860 | cites work | Breeding of a non-obese, diabetic strain of mice | Q28276534 |
| Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23) | Q33592891 | ||
| In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice | Q34224719 | ||
| Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues | Q35093806 | ||
| Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance | Q35878983 | ||
| Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice | Q36678330 | ||
| Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice | Q36736666 | ||
| Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen | Q37401915 | ||
| Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit | Q37494112 | ||
| Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin | Q37622936 | ||
| Could specific oral tolerance be a therapy for autoimmune disease? | Q37783108 | ||
| Defence against allergic sensitization in the healthy lung: the role of inhalation tolerance. | Q38648476 | ||
| Insulin-dependent diabetes mellitus as an autoimmune disease | Q40648707 | ||
| Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens | Q40661200 | ||
| Anergic T cells as suppressor cells in vitro | Q41461549 | ||
| Inhibition of specific immune responses by feeding protein antigens. II. Effects of prior passive and active immunization | Q41633022 | ||
| Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen | Q41742673 | ||
| Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes | Q41789085 | ||
| Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats | Q44815781 | ||
| Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein | Q46690191 | ||
| Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease | Q47346480 | ||
| Double-Blind Pilot Trial of Oral Tolerization with Myelin Antigens in Multiple Sclerosis | Q50127386 | ||
| Genetic control of diabetogenesis in NOD/Lt mice. Development and analysis of congenic stocks. | Q54342084 | ||
| Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. | Q55066037 | ||
| Pancreatic Lymph Nodes are Early Targets of T Cells during Adoptive Transfer of Diabetes in NOD Mice | Q60585139 | ||
| The involvement of Ly 2+ T cells in beta cell destruction | Q61651751 | ||
| Oral hyposensitization of children with pollinosis or house-dust asthma | Q67582219 | ||
| Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice | Q68889645 | ||
| The induction of tolerance to a soluble protein antigen by oral administration | Q68928457 | ||
| Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments | Q69013296 | ||
| Influence of Repeated Administration of Antigen by the Oral Route on Specific Antibody-Producing Cells in the Mouse Spleen | Q69313330 | ||
| Insulin Antibodies in Insulin-Dependent Diabetics Before Insulin Treatment | Q70311233 | ||
| Clinical and immunological response to oral and subcutaneous immunotherapy with grass pollen extracts. A prospective study | Q70478605 | ||
| Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor | Q70745453 | ||
| Large-scale production of Vibrio cholerae toxin B subunit for use in oral vaccines | Q72271829 | ||
| Oral administration of human insulin to NOD mice generates CD4+ T cells that suppress adoptive transfer of diabetes | Q72495278 | ||
| Orally induced tolerance. Definition at the cellular level | Q72636644 | ||
| Effects of oral administration of type II collagen on rheumatoid arthritis | Q72936919 | ||
| Inhibition of Experimental Drug Allergy by Prior Feeding of the Sensitizing Agent | Q82174999 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cholera | Q12090 |
| vaccine | Q134808 | ||
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 4610-4614 | |
| P577 | publication date | 1997-04-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes | |
| P478 | volume | 94 |
| Q50126055 | A cloning vector for efficient generation of cholera toxin B gene fusions for epitope screening |
| Q63370226 | A mucosally administered recombinant fusion protein vaccine against schistosomiasis protecting against immunopathology and infection |
| Q27633142 | A mutant cholera toxin B subunit that binds GM1- ganglioside but lacks immunomodulatory or toxic activity |
| Q45889680 | A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes |
| Q33722430 | A single point mutation within the coding sequence of cholera toxin B subunit will increase its expression yield |
| Q35155875 | AB toxins: a paradigm switch from deadly to desirable |
| Q45884563 | An HIV-1 tat-autoantigen fusion protein suppresses insulitis in NOD mice |
| Q37001778 | Anti-inflammatory effect of cholera toxin B subunit in experimental stroke |
| Q35762883 | Antigen-specific therapeutic approaches in Type 1 diabetes |
| Q37869564 | Autoantigen based vaccines for type 1 diabetes. |
| Q34113929 | Autoantigens plus interleukin-10 suppress diabetes autoimmunity |
| Q45889466 | Bacterial and plant enterotoxin B subunit-autoantigen fusion proteins suppress diabetes insulitis |
| Q35924786 | Chimeric Vaccine Stimulation of Human Dendritic Cell Indoleamine 2, 3-Dioxygenase Occurs via the Non-Canonical NF-κB Pathway |
| Q39522002 | Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells |
| Q36551840 | Cholera toxin B subunit linked to glutamic acid decarboxylase suppresses dendritic cell maturation and function. |
| Q39971245 | Cholera toxin B subunit promotes the induction of regulatory T cells by preventing human dendritic cell maturation |
| Q40813264 | Cholera toxin and Escherichia coli enterotoxin B-subunits inhibit macrophage-mediated antigen processing and presentation: evidence for antigen persistence in non-acidic recycling endosomal compartments |
| Q39741614 | Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development |
| Q37376821 | Cholera toxin subunit B peptide fusion proteins reveal impaired oral tolerance induction in diabetes-prone but not in diabetes-resistant mice. |
| Q24598726 | Cholera toxin: a paradigm of a multifunctional protein |
| Q37954306 | Cholera-like enterotoxins and Regulatory T cells |
| Q35473462 | Cholera-toxin suppresses carcinogenesis in a mouse model of inflammation-driven sporadic colon cancer |
| Q90355622 | Consuming cholera toxin counteracts age-associated obesity |
| Q46467726 | Correlation between adjuvanticity and immunogenicity of cholera toxin B subunit in orally immunised young chickens |
| Q73943062 | Coupling of oral human or porcine insulin to the B subunit of cholera toxin (CTB) overcomes critical antigenic differences for prevention of type I diabetes |
| Q35116303 | Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same? |
| Q78445849 | Diminished immunopathology in Schistosoma mansoni infection following intranasal administration of cholera toxin B-immunodominant peptide conjugate correlates with enhanced transforming growth factor-beta production by CD4 T cells |
| Q74401546 | Efficacy of a food plant-based oral cholera toxin B subunit vaccine |
| Q36591189 | Expression of a ricin toxin B subunit: insulin fusion protein in edible plant tissues |
| Q53030473 | Expression of cholera toxin B subunit-lumbrokinase in edible sunflower seeds-the use of transmucosal carrier to enhance its fusion protein's effect on protection of rats and mice against thrombosis. |
| Q36990434 | Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts--oral administration protects against development of insulitis in non-obese diabetic mice |
| Q33949282 | Extra-thymically induced regulatory T cells: do they have potential in disease prevention? |
| Q73507054 | Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies |
| Q54544388 | Genetic fusion of human insulin B-chain to the B-subunit of cholera toxin enhances in vitro antigen presentation and induction of bystander suppression in vivo. |
| Q84081029 | Glutamic acid decarboxylase epitope protects against autoimmune diabetes through activation of Th2 immune response and induction of possible regulatory mechanism |
| Q33786936 | Gut and the induction of immune tolerance in type 1 diabetes |
| Q48105339 | IL-6 Inhibits Upregulation of Membrane-Bound TGF-β 1 on CD4+ T Cells and Blocking IL-6 Enhances Oral Tolerance |
| Q38971911 | Identification of Helicobacter pylori and the evolution of an efficacious childhood vaccine to protect against gastritis and peptic ulcer disease |
| Q34102006 | Immune modulation by the cholera-like enterotoxin B-subunits: from adjuvant to immunotherapeutic |
| Q33546865 | Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic |
| Q34099969 | Immune therapy for type 1 diabetes mellitus-what is unique about anti-CD3 antibodies? |
| Q37642859 | Immunomodulation of gut-associated lymphoid tissue: current perspectives |
| Q34184898 | Immunomodulation using bacterial enterotoxins |
| Q36320323 | Immunomodulation with enterotoxins for the generation of secretory immunity or tolerance: applications for oral infections |
| Q34118463 | Immunotherapy of immune-mediated diabetes. Present and future |
| Q34731064 | Immunotherapy of type 1 diabetes: lessons for other autoimmune diseases |
| Q33815506 | Immunotherapy of type 1 diabetes: where are we and where should we be going? |
| Q35122841 | Induction of indoleamine 2, 3-dioxygenase in human dendritic cells by a cholera toxin B subunit-proinsulin vaccine. |
| Q28770045 | Induction of thymus-derived gammadelta T Cells by Escherichia coli enterotoxin b subunit in peritoneal cavities of mice |
| Q33769366 | Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue |
| Q30350670 | Is there a role for plant-made vaccines in the prevention of HIV/AIDS? |
| Q34257271 | Loss of sialic acid binding domain redirects protein σ1 to enhance M cell-directed vaccination |
| Q37069755 | Low-dose tolerance is mediated by the microfold cell ligand, reovirus protein sigma1. |
| Q36743545 | MAPK phosphatases--regulating the immune response |
| Q54542514 | Modulation of human monocytes by Escherichia coli heat-labile enterotoxin B-subunit; altered cytokine production and its functional consequences. |
| Q42854644 | Modulation of systemic antigen-specific immune responses by oral antigen in humans. |
| Q35192183 | Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. |
| Q36787542 | Mucosal exposure to antigen: cause or cure of type 1 diabetes? |
| Q35134733 | Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges |
| Q33776172 | Mucosal immunity and tolerance: relevance to vaccine development |
| Q34409172 | Mucosal immunity and vaccines |
| Q34715639 | Mutant Escherichia coli heat-labile toxin B subunit that separates toxoid-mediated signaling and immunomodulatory action from trafficking and delivery functions |
| Q36514958 | Myeloperoxidase Peptide-Based Nasal Tolerance in Experimental ANCA-Associated GN. |
| Q78402068 | Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice |
| Q34564255 | New therapeutic approaches to type 1 diabetes: from prevention to cellular or gene therapies |
| Q35897441 | Oral Administration of Silkworm-Produced GAD65 and Insulin Bi-Autoantigens against Type 1 Diabetes |
| Q41174004 | Oral administration of Alequel, a mixture of autologous colon-extracted proteins for the treatment of Crohn's disease |
| Q43683297 | Oral administration of collagen conjugated with cholera toxin induces tolerance to type II collagen and suppresses chondritis in an animal model of autoimmune ear disease |
| Q36083396 | Oral delivery of Acid Alpha Glucosidase epitopes expressed in plant chloroplasts suppresses antibody formation in treatment of Pompe mice |
| Q51554328 | Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group. |
| Q43040918 | Oral tolerance in disease |
| Q79859166 | Oral tolerance induction by mucosal administration of cholera toxin B-coupled antigen involves T-cell proliferation in vivo and is not affected by depletion of CD25+ T cells |
| Q33683196 | Oral tolerance: mechanisms and therapeutic applications. |
| Q24548763 | Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection |
| Q37638227 | Plant-based vaccines for oral delivery of type 1 diabetes-related autoantigens: Evaluating oral tolerance mechanisms and disease prevention in NOD mice |
| Q50117900 | Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization |
| Q33937758 | Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetope |
| Q73882350 | Production of a recombinant hybrid molecule of cholera toxin-B-subunit and proteolipid-protein-peptide for the treatment of experimental encephalomyelitis |
| Q35016963 | Prospects for the prevention and reversal of type 1 diabetes mellitus |
| Q35101668 | Protection against autoimmune diabetes by silkworm-produced GFP-tagged CTB-insulin fusion protein. |
| Q54471977 | Protection of non-obese diabetic mice from autoimmune diabetes by Escherichia coli heat-labile enterotoxin B subunit. |
| Q36161912 | Refinement of polyclonal antibody production by combining oral immunization of chickens with harvest of antibodies from the egg yolk. |
| Q41628549 | Role of T-cell anergy and suppression in susceptibility to IDDM. |
| Q77725121 | Selective immunotherapy of IDDM: a discussion based on new findings from the RIP-LCMV model for autoimmune diabetes |
| Q52681524 | Sublingual 'oral tolerance' induction with antigen conjugated to cholera toxin B subunit generates regulatory T cells that induce apoptosis and depletion of effector T cells. |
| Q34629092 | Suppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit. |
| Q42035404 | Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunit-insulin B chain fusion protein vaccine produced in silkworm |
| Q40710316 | Synthesis of cholera toxin B subunit gene: cloning and expression of a functional 6XHis-tagged protein in Escherichia coli. |
| Q37805563 | T-cell autoantigens in the non-obese diabetic mouse model of autoimmune diabetes |
| Q46801670 | The Escherichia coli heat-labile enterotoxin induces apoptosis of immature lymphocytes in vivo via a glucocorticoid-dependent pathway |
| Q39233053 | The Role of Dendritic Cell Maturation in the Induction of Insulin-Dependent Diabetes Mellitus |
| Q26785900 | The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity |
| Q40564857 | The cholera toxin B subunit directly costimulates antigen-primed CD4+ T cells ex vivo |
| Q47904800 | The cholera toxin B subunit is a mucosal adjuvant for oral tolerance induction in type 1 diabetes |
| Q50947582 | The recombinant fusion protein of cholera toxin B and neutrophil-activating protein expressed on Bacillus subtilis spore surface suppresses allergic inflammation in mice. |
| Q47964824 | The role of the gut in beta-cell autoimmunity and type 1 diabetes: a hypothesis |
| Q47105986 | Therapeutic Potential of Cholera Toxin B Subunit for the Treatment of Inflammatory Diseases of the Mucosa |
| Q35790348 | Therapeutic potential of oral tolerance |
| Q33713298 | Transgenes and knockout mutations in animal models of type 1 diabetes and multiple sclerosis |
| Q34327132 | Treg vaccination with a strong-agonistic insulin mimetope |
| Q57988037 | Use of a genetic cholera toxin B subunit/allergen fusion molecule as mucosal delivery system with immunosuppressive activity against Th2 immune responses |
| Q37052632 | Vaccination against self to prevent autoimmune disease: the type 1 diabetes model |
| Q34610624 | Vaccination strategies to promote mucosal antibody responses. |
Search more.